Pharmacy / Pharmacology - What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model
Can't see this email? View it online
   
  Pharmacy / Pharmacology  
  The latest pharmacy / pharmacology news from News Medical  
 

#ALT# Stop contamination with pharma grade flex barriers

Compliance with regulations and ensuring safety of processes is a top requirement for production of pharmaceuticals. To ensure no batch-to-batch contamination, the pump systems must be easy to clean and drain. (Made from purest PTFE resin), Saint-Gobain’s pharma-grade Flex barriers offer excellent flexibility and high smoothness for improved cleaning ability, while bondable versions allow for lamination to rubber carriers.

Find Out More
 
   What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational modelWhat is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model
 
A team of scientists from the Pennsylvania State University, USA, recently analyzed the pharmacodynamics and pharmacokinetics of antiviral drug remdesivir using computational models.
 
   New molecule extracted from the leaves of chestnut tree neutralizes staph bacteriaNew molecule extracted from the leaves of chestnut tree neutralizes staph bacteria
 
Scientists isolated a molecule, extracted from the leaves of the European chestnut tree, with the power to neutralize dangerous, drug-resistant staph bacteria. Frontiers in Pharmacology published the finding, led by scientists at Emory University.
 
 Sunflower peptide identified as a potential drug for treating abdominal pain
 
Sunflower peptide identified as a potential drug for treating abdominal painA naturally occurring peptide in sunflower seeds was synthetically optimised and has now been identified as a potential drug for treating abdominal pain or inflammation (in the gastrointestinal tract, abdominal area and/or internal organs).
 
 
 Women who use hormonal contraceptives face higher risk of developing glaucoma
 
Women who use hormonal contraceptives face higher risk of developing glaucomaWomen who currently use hormonal contraceptives face more than a 2-fold higher risk of developing glaucoma, according to an analysis of electronic medical records for women aged 15-45 years from 2008 to 2018.
 
 
 Research finds Cannabis terpenes as a promising new target for pain therapies
 
Research finds Cannabis terpenes as a promising new target for pain therapiesWhen it comes to the medicinal and therapeutic properties of Cannabis sativa, an unsolved mystery is whether there exists an "entourage effect," whereby the pain-relieving effects of the plant as a whole are greater than any of its individual parts.